Online citations, reference lists, and bibliographies.
← Back to Search

Synthesis Of High Loading And Encapsulation Efficient Paclitaxel-loaded Poly(n-butyl Cyanoacrylate) Nanoparticles Via Miniemulsion.

C. Huang, C. Chen, Yu-Der Lee
Published 2007 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The manufacture of stable paclitaxel-loaded poly(n-butyl cyanoacrylate) (PBCA) nanoparticles containing high loading and encapsulation efficiency simultaneously were achieved in the presence of pluronic F127 via miniemulsion. It was found that both drug loading and encapsulation efficiencies of PBCA nanoparticles prepared by miniemulsion were higher (approximately three times) than those obtained by emulsion with similar paclitaxel content in the feed monomer (1%, w/w). Furthermore, the loading and encapsulation efficiencies increased concurrently (to a maximum of 4 and 80%, respectively) with increasing paclitaxel content and these nanoparticles were spherical in shape and with size near 100 nm. XRD patterns revealed that paclitaxel in particles was distributed in the molecular or amorphous state or in the form of small crystals. The in vitro drug release profile of drug-loaded PBCA nanoparticles prepared from miniemulsion exhibited a gradual release; more than 80% (w/w) of the paclitaxel was released after 96 h.
This paper references
10.1016/S0168-3659(00)00364-3
Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.
S. Feng (2001)
10.1002/JPS.2600690222
Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles.
P. Couvreur (1980)
10.1016/0378-5173(96)04550-4
Mitoxantrone polybutyl cyanoacrylate nanoparticles as an anti-neoplastic targeting drug delivery system
Z. Zhang (1996)
10.1016/0378-5173(86)90131-6
Evaluation of carrier capacity and release characteristics for poly( butyl 2-cyanoacrylate) nanoparticles
L. Illum (1986)
10.1023/A:1015819706491
Vidarabine-Loaded Nanoparticles: A Physicochemical Study
V. Guise (2004)
10.1002/MACP.200500372
Preparation of Fluorescent Carboxyl and Amino Functionalized Polystyrene Particles by Miniemulsion Polymerization as Markers for Cells
V. Holzapfel (2005)
10.1016/0378-5173(92)90209-K
Alkylcyanoacrylate drug carriers. I : Physicochemical characterization of nanoparticles with different alkyl chain length
R. Müller (1992)
10.1002/1099-0518(20001215)38:24<4431::AID-POLA120>3.0.CO;2-Y
Encapsulation of inorganic particles via miniemulsion polymerization. II. Preparation and characterization of styrene miniemulsion droplets containing TiO2 particles
Bedri Erdem (2000)
10.1016/0021-9797(85)90087-6
Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers
S. J. Douglas (1985)
10.1016/S0141-3910(02)00113-1
Hydrolysis of poly (n-butylcyanoacrylate) nanoparticles using esterase
C. O'sullivan (2002)
10.1023/A:1011982211632
Combined Poly(isobutylcyanoacrylate) and Cyclodextrins Nanoparticles for Enhancing the Encapsulation of Lipophilic Drugs
A. M. da Silveira (2004)
10.1016/S0169-409X(03)00041-3
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
10.1016/S0032-3861(97)10347-0
Miniemulsion polymerization of styrene in the presence of a water-insoluble blue dye
C. Chern (1998)
10.1016/S0169-409X(02)00016-9
Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations.
R. Liggins (2002)
10.1016/0168-3659(90)90013-J
Nanocapsules as carriers for oral peptide delivery
C. Damgé (1990)
10.1016/S0928-0987(97)86242-2
Nanoparticles as carriers for oral peptide delivery
Shinji Sakuma (1996)
10.1021/MA035154O
Comparison of Conventional and Miniemulsion Copolymerizations of Acrylic Monomers Using Poly(vinyl alcohol) as the Sole Stabilizer
Noma Kim (2004)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.1023/A:1018938026615
Poly(Alkylcyanoacrylate) Nanocapsules: Physicochemical Characterization and Mechanism of Formation
F. Chouinard (2004)
10.1016/J.JCONREL.2003.08.005
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.
C. Vauthier (2003)
10.1016/0168-3659(94)00060-8
Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin
C. Tasset (1994)
10.1016/J.JCONREL.2003.07.001
Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel.
T. Ooya (2003)
10.1016/0378-5173(87)90146-3
Polyalkylcyanoacrylate nanocapsules increase the intestinal absorption of a lipophilic drug
C. Damgé (1987)
10.1002/1521-3900(200002)151:1<549::AID-MASY549>3.0.CO;2-D
Miniemulsion polymerization: Applications and new materials.
N. Bechthold (2000)
10.1016/S0378-5173(01)00986-3
Paclitaxel and its formulations.
A. K. Singla (2002)
10.1016/0169-409X(90)90017-M
Nanoparticles as microcarriers for anticancer drugs
P. Couvreur (1990)
10.1021/MA990299+
Formulation and stability mechanisms of polymerizable miniemulsions
K. Landfester (1999)
10.1021/BM049234R
Formation of core/shell nanoparticles with a lipid core and their application as a drug delivery system.
K. S. Oh (2005)
10.1211/0022357021341
Effect of surfactant on fabrication and characterization of paclitaxel‐loaded polybutylcyanoacrylate nanoparticulate delivery systems
A. Mitra (2003)
10.1016/S0378-5173(03)00211-4
Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation.
Y. Li (2003)
10.1201/9781498710565
Colloidal Drug Delivery Systems
J. Kreuter (1994)
10.1016/0140-6736(93)92789-V
Cremophor EL, solvent for paclitaxel, and toxicity
J. Liebmann (1993)
10.1021/JS9605226
Solid-state characterization of paclitaxel.
R. Liggins (1997)
10.1016/S0079-6700(01)00051-X
Polyreactions in miniemulsions
M. Antonietti (2002)
10.1080/02652040110081352
Cyclophosphamide-loaded nanospheres: analysis of the matrix structure by thermal and spectroscopic methods
A. Salgueiro (2002)
10.1016/S0378-5173(98)00015-5
Adsorption of polysorbate 80 on pyrantel pamoate : effects on suspension stability
R. Duro (1998)
10.1016/0021-9797(84)90015-8
Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: I. Influence of physicochemical factors
S. J. Douglas (1984)
10.1016/S0168-3659(02)00320-6
A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.
L. Mu (2003)
10.1016/0168-3659(92)90081-2
Intracellular targeting of antibiotics by means of biodegradable nanoparticles
P. Couvreur (1992)
10.1093/AJHP/48.7.1520
Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.
W. Waugh (1991)
10.1007/S00396-003-0902-5
Preparation of colored latex containing oil-soluble dyes with high dye content by mini-emulsion polymerization
Mayuko Takasu (2003)
10.1016/0142-9612(84)90002-4
Degradation of poly (isobutyl cyanoacrylate) nanoparticles.
V. Lenaerts (1984)
10.1002/(SICI)1097-0215(19970328)71:1<103::AID-IJC17>3.0.CO;2-J
Activity of paclitaxel liposome formulations against human ovarian tumor xenografts
A. Sharma (1997)
10.1002/PI.1029
Encapsulation of an organic phthalocyanine blue pigment into polystyrene latex particles using a miniemulsion polymerization process
S. Lélu (2003)
10.1016/S0142-9612(03)00419-8
Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
G. Ruan (2003)
10.1016/J.IJPHARM.2006.06.008
Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation.
C. Huang (2006)



This paper is referenced by
10.1007/S13233-011-1105-4
Influence of glyceryl palmitostearate on release behaviors of hydroxypropyl cellulose microcapsules containing indomethacin by W/O emulsion
K. Kim (2011)
10.2147/IJN.S16570
Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles
Xin-hua Tian (2011)
10.1007/s11095-011-0510-x
Opsonization, Biodistribution, Cellular Uptake and Apoptosis Study of PEGylated PBCA Nanoparticle as Potential Drug Delivery Carrier
K. Chaudhari (2011)
10.1007/S11051-010-9907-4
Enhancement of transport of curcumin to brain in mice by poly(n-butylcyanoacrylate) nanoparticle
M. Sun (2010)
10.15171/apb.2020.005
Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells
A. Akbari (2020)
Degradation and Stability of PBCA and POCA Nanoparticles
A. Bøe (2013)
10.3109/1061186X.2015.1020426
Polybutylcyanoacrylate nanocarriers as promising targeted drug delivery systems
Shiya Gao (2015)
10.1016/j.colsurfb.2011.11.048
Influence of 1-D silica nanotubes as drug adsorbent on release behaviors of tulobuterol-loaded porous microcapsules.
K. Kim (2012)
Microencapsulation by complex coacervation of fish oil using gelatin/SDS/NaCMC
Kamdem Eugene (2013)
10.1016/j.colsurfb.2018.10.002
Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
X. Jin (2019)
10.1080/03639040701842444
Paclitaxel-Loaded Microparticles for Intratumoral Administration via the TMT Technique: Preparation, Characterization, and Preliminary Antitumoral Evaluation
M. Hamoudeh (2008)
10.1007/s11051-011-0705-4
Evaluation of an oral carrier system in rats: bioavailability and gastrointestinal absorption properties of curcumin encapsulated PBCA nanoparticles
M. Sun (2012)
10.1016/J.JDDST.2019.101194
Mucoadhesive paclitaxel-loaded chitosan-poly (isobutyl cyanoacrylate) core-shell nanocapsules containing copaiba oil designed for oral drug delivery
Francisco Humberto Xavier-Jr. (2019)
10.1002/APP.33518
Taxol-loaded nanoparticles with methoxy poly(ethylene glycol)-b-poly(ε-caprolactone) as a novel additive in the outer aqueous phase
Y. Zhang (2011)
10.1007/s11095-010-0346-9
Paclitaxel-Loaded Poly(n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer
Fei Ren (2010)
10.1007/s11095-008-9800-3
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
10.1016/j.ejps.2020.105397
Lipid-core nanocapsules containing simvastatin improve the cognitive impairment induced by obesity and hypercholesterolemia in adult rats.
R. Lorenzoni (2020)
10.1016/j.colsurfb.2010.06.017
Effect of porous silica on sustained release behaviors of pH sensitive pluronic F127/poly(acrylic acid) hydrogels containing tulobuterol.
K. Kim (2010)
10.1016/j.ijpharm.2014.12.070
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Y. Kuo (2015)
10.3109/03639045.2012.704042
Incorporation of paclitaxel solid dispersions with poloxamer188 or polyethylene glycol to tune drug release from poly(ϵ-caprolactone) films
Yanqing Shen (2013)
10.3390/ijms151223909
PLGA Biodegradable Nanoparticles Containing Perphenazine or Chlorpromazine Hydrochloride: Effect of Formulation and Release
Mohammed Halayqa (2014)
10.1016/j.colsurfb.2008.10.003
Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization. 2. PEG-based surfactants.
M. Wu (2009)
Development of multifunctional polymeric nanoparticles by nano-emulsion templating as advanced nanocarriers targeting the blood-brain barrier
Cristina Fornaguera Puigvert (2015)
10.1007/978-3-030-41838-0_6
An Overview of Paclitaxel Delivery Systems
A. Prabakaran (2020)
10.1016/j.ijpharm.2016.09.067
Herceptin-functionalized pure paclitaxel nanocrystals for enhanced delivery to HER2-postive breast cancer cells.
Jin-Ki Noh (2016)
10.1016/j.ijpharm.2010.08.033
Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
Jinghua Duan (2010)
10.13023/ETD.2016.024
BIOACTIVE POLY(BETA-AMINO ESTER) BIOMATERIALS FOR TREATMENT OF INFECTION AND OXIDATIVE STRESS
Andrew L. Lakes (2016)
Optimization Process by Complex Coacervation of Fish Oil using Gelatin/ SDS/ NaCMC and Secondary Coating Application with Sodium Polyphosphate.
Patrick Kamdem Eugene (2014)
10.3390/ph13030044
Preparation, Characterization, and Evaluation of Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved In Vitro and In Vivo Anticancer Activities
Mohsen Ghaferi (2020)
10.1007/s11051-012-0761-4
Folate-decorated chitosan/doxorubicin poly(butyl)cyanoacrylate nanoparticles for tumor-targeted drug delivery
Jinghua Duan (2012)
10.1517/17425247.2013.772976
Nanocapsules with specific targeting and release properties using miniemulsion polymerization
K. Landfester (2013)
Cellular Interaction with Polymeric Nanoparticles: The Effect of PEGylation and Monomer Composition
S. Westrøm (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar